The British journal of cardiology最新文献_第10页

Atrial fibrillation prevalence and predictors in patients with diabetes: a cross-sectional screening study. 糖尿病患者房颤患病率及预测因素:一项横断面筛查研究。

The British journal of cardiology Pub Date : 2022-03-08 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.008

Angela Hall, Andrew Robert John Mitchell, Lisa Ashmore, Carol Holland

{"title":"Atrial fibrillation prevalence and predictors in patients with diabetes: a cross-sectional screening study.","authors":"Angela Hall, Andrew Robert John Mitchell, Lisa Ashmore, Carol Holland","doi":"10.5837/bjc.2022.008","DOIUrl":"https://doi.org/10.5837/bjc.2022.008","url":null,"abstract":"Prevalence of atrial fibrillation (AF) and diabetes is increasing worldwide. Diabetes is a risk factor for AF and both increase stroke risk. Previous AF screening studies have recruited highrisk patient groups, but not with diabetes as the target group. This study aims to determine whether people with diabetes have a higher prevalence of AF than the general population and investigate whether determinants, such as diabetes duration or diabetes control, add to AF risk. In a cross-sectional screening study, patients with diabetes were recruited via their GP surgeries or a diabetes centre. A 30-second single-lead electrocardiogram (ECG) was recorded using the Kardia® device, along with physiological measurements and details relating to risk factor variables. There were 300 participants recruited and 16 patients identified with AF (5.3% prevalence). This demonstrated a significantly greater likelihood of AF than the background population (p=0.043). People with diabetes and AF were significantly older than those who only had diabetes. More people with type 2 diabetes had AF than people with type 1. Prediction of AF diagnosis by age, sex, diabetes type, diabetes duration and level of control revealed only age as a significant predictor. In conclusion, these findings add to existing data around the association of these chronic conditions, supporting AF screening in this high-risk group, particularly in those of older age. This can contribute to appropriate management of both conditions in combination, not least with regards to stroke prevention.","PeriodicalId":74959,"journal":{"name":"The British journal of cardiology","volume":"29 1","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2022-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196068/pdf/BJC-29-01-bjc.2022.008.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40392262","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

Heart failure care pathways: the power of collaboration and marginal gains. 心力衰竭护理途径:合作的力量和边际收益。

The British journal of cardiology Pub Date : 2022-01-26 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.005

Carys Barton, Simon Gordon, Afsana Safa, Carla M Plymen

引用次数: 0

Effect of the COVID-19 pandemic on ST-elevation myocardial infarction presentation and survival. COVID-19大流行对st段抬高型心肌梗死表现和生存的影响

The British journal of cardiology Pub Date : 2022-01-26 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.004

Sachintha Perera, Sudhir Rathore, Joanne Shannon, Peter Clarkson, Matthew Faircloth, Vinod Achan

{"title":"Effect of the COVID-19 pandemic on ST-elevation myocardial infarction presentation and survival.","authors":"Sachintha Perera, Sudhir Rathore, Joanne Shannon, Peter Clarkson, Matthew Faircloth, Vinod Achan","doi":"10.5837/bjc.2022.004","DOIUrl":"https://doi.org/10.5837/bjc.2022.004","url":null,"abstract":"Presentation and outcomes of patients with ST-elevation myocardial infarction (STEMI) may change during viral pandemics. We compared symptom-tocall (STC), call-to-balloon (CTB), doorto-balloon (DTB) times; high-sensitivity troponin (hs-cTnI) levels; and survival of patients (n=39) during the first wave of the COVID-19 pandemic (defined as a 'COVID period' starting four weeks before lockdown) to historical controls from a 'pre-COVID period' (n=45). STEMI admissions fell one week before lockdown by 29%. Median STC times began to rise one month before lockdown (54 vs. 25 min, p=0.06), with peak increases between 9 March and 5 April (166 vs. 59 min, p=0.04). Median CTB and DTB times were unchanged. Mean peak hs-cTnI increased during COVID-19 (15,225 vs. 8,852 ng/ml, p=0.004). Six-month survival following all STEMI reduced (82.1% vs. 95.6%, p<0.05). STC times are the earliest indicator that STEMI-patient behaviour changed four weeks before lockdown, correlating with higher troponin levels and reduced survival. These early signals could guide public health interventions during future pandemics.","PeriodicalId":74959,"journal":{"name":"The British journal of cardiology","volume":"29 1","pages":"4"},"PeriodicalIF":0.0,"publicationDate":"2022-01-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9196070/pdf/BJC-29-01-bjc.2022.004.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40392261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Improving DVLA advice upon discharge after cardiac device implantation. 改进心脏装置植入术后出院时的 DVLA 建议。

The British journal of cardiology Pub Date : 2022-01-26 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.006

Arsalan Khalil, Tamara Naneishvili, Abigail Mayo-Evans, James Glancy

引用次数: 0

Observational case series of postural tachycardia syndrome (PoTS) in post-COVID-19 patients. 新冠肺炎后体位性心动过速综合征(PoTS)观察病例系列。

The British journal of cardiology Pub Date : 2022-01-26 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.003

Nicholas P Gall, Stephen James, Lesley Kavi

引用次数: 5

New agents for DOAC reversal: a practical management review. 用于DOAC逆转的新药物:一项实用的管理综述。

The British journal of cardiology Pub Date : 2022-01-12 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.001

Katie White, Uzma Faruqi, Alexander Ander T Cohen

引用次数: 9

Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy. HFrEF的基础药物:快速测序策略的越来越多证据。

The British journal of cardiology Pub Date : 2022-01-12 eCollection Date: 2022-01-01 DOI: 10.5837/bjc.2022.002

Kieran F Docherty, John J V McMurray

{"title":"Foundational drugs for HFrEF: the growing evidence for a rapid sequencing strategy.","authors":"Kieran F Docherty, John J V McMurray","doi":"10.5837/bjc.2022.002","DOIUrl":"https://doi.org/10.5837/bjc.2022.002","url":null,"abstract":"In randomised, placebo- or active-controlled trials in patients with heart failure with reduced ejection fraction (HFrEF), each of the combination of a neprilysin inhibitor and an angiotensin-receptor blocker (i.e. sacubitril/valsartan), a beta blocker, a mineralocorticoidreceptor antagonist and a sodium-glucose co-transporter 2 (SGLT2) inhibitor have been shown to reduce morbidity and mortality, firmly establishing the role of these five agents, prescribed as four pills, as foundational therapy for HFrEF. Traditionally, the guideline-advocated strategy for the initiation of these therapies was based on the historical order in which the landmark clinical trials were performed, and the requirement to uptitrate each individual drug to the target dose (or maximally tolerated dose below this) prior to initiation of another therapy. This process could take six months or more to complete, during which time patients would not be taking one or more of these life-saving drugs. Recently an alternative, evidence-based, rapid three-step sequencing strategy has been proposed with the aim of establishing HFrEF patients on low-doses of all four foundational treatments within four weeks. This strategy is based on the premise that the benefits of each of these therapies are independent and additive to the others, the benefits are apparent at low doses early following initiation, and a specific ordering of therapies may increase likelihood of tolerance of others. This article will outline this novel rapid-sequencing strategy and provide an evidence-based framework to support its adoption into clinical practice.","PeriodicalId":74959,"journal":{"name":"The British journal of cardiology","volume":"29 1","pages":"2"},"PeriodicalIF":0.0,"publicationDate":"2022-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198897/pdf/BJC-29-01-bjc.2022.002.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40391666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Marijuana: cardiovascular effects and legal considerations. A clinical case-based review. 大麻:心血管影响和法律考虑。一项基于临床病例的综述。

The British journal of cardiology Pub Date : 2022-01-01 DOI: 10.5837/bjc.2022.011

Saad Ahmad, Shwe Win Hlaing, Muhammad Haris, Nadeem Attar

引用次数: 3

Infective endocarditis: acne to zoonoses on the valve, an A to Z perspective. 感染性心内膜炎:痤疮对人畜共患病的瓣膜，从A到Z的角度。

The British journal of cardiology Pub Date : 2022-01-01 DOI: 10.5837/bjc.2022.025

Mark Boyle, Charlene Tennyson, Achyut Guleri, Antony Walker

引用次数: 0

How to measure lipoprotein(a) and in whom 如何测量脂蛋白(a)，在哪些人群中测量

The British journal of cardiology Pub Date : 2022-01-01 DOI: 10.5837/bjc.2022.s04

引用次数: 1